Abacavir Sulfate/Lamivudine/Zidovudine

硫酸阿巴卡韦/拉米夫定/齐多夫定

Report date: 2023/04/25 14:17:07

Base Information

Drug NameAbacavir Sulfate/Lamivudine/Zidovudine
Drug Alias Name阿巴卡韦双夫定Abacavir/lamivudine/zidovudineAbacavir - lamivudine - zidovudineZidovudine, lamivudine and abacavirabacavir, lamivudine and zidovudine +[9] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsReverse transcriptase inhibitors
TargetsReverse transcriptaseHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2000/11/14
Country/TerritoryUnited StatesNetherlandsEU +[4] 
CombinationsYes LamivudineZidovudineAbacavir Sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesViiv Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesViiv Healthcare BvViiv Healthcare Uk Ltd
Inactive CompaniesGlaxosmithkline PlcViiv Healthcare Co
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AR04
Related LinksWikipediaKEGG